Revital Healthcare

What Revital Healthcare does

Revital Healthcare, legally Revital Healthcare EPZ Ltd, is a privately held Kenyan medical-device manufacturer headquartered in Kilifi. Established in 2008, it supplies public and private healthcare systems in Kenya and export markets with syringes, rapid diagnostic tests, catheters, needles, blood-collection products, infusion and transfusion equipment, neonatal respiratory devices, personal protective equipment, and other disposables. The portfolio is reported at more than 48 medical devices.

The company's principal differentiator is an early-activation auto-disable syringe that disables at the start of an injection to prevent reuse and reduce blood-borne infections; the input describes it as Africa's first patented design and a WHO-PQS-prequalified product. Revital also produces the REFLON passive-safety intravenous cannula and the non-electric VAYU bubble CPAP system for neonatal respiratory support, alongside rapid tests for HIV, malaria, COVID-19, hepatitis B and C, dengue, pregnancy, and syphilis. Reported capacity includes more than 300 million auto-disable syringes annually, 240 million rapid tests per year, and 2.1 billion medical devices in total annual capacity.

Revenue is generated primarily through one-time B2B sales to government health agencies, NGOs, UNICEF, WHO, other international health organizations, and private healthcare providers, supplemented by distributors. The go-to-market model uses direct institutional contracts and tenders alongside regional distribution, with exports reported across 28–35 countries. No consumer pricing is publicly disclosed; the only concrete contract value cited is KES 150 million for 50 million COVID-19 syringes supplied to UNICEF India.

Name

Revital Healthcare

Legal name

Revital Healthcare EPZ Ltd

Website

https://revitalhcare.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Revital Healthcare is a Kenyan manufacturer of syringes, rapid diagnostic tests, catheters, respiratory devices, and medical disposables sold to governments, NGOs, international health organizations, distributors, and healthcare providers across Africa and other export markets.

Ownership category

akta.pro rank

Product category

Medical Device Manufacturing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

akta.pro secondary industries

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Vaccine Procurement, Tendering & Immunization Supply Programs (HLAIAEAN)

Keywords

• Medical device manufacturing
• Auto-disable syringes
• Rapid diagnostic tests
• Catheters and tubing
• Neonatal respiratory devices

Headquarters

HQ city

Kilifi

HQ country

Kenya

HQ region

Africa

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of manufactured medical devices including syringes, rapid diagnostic tests, catheters, and other medical disposables to governments, NGOs, and private healthcare providers. One-time purchase model for medical consumables.
2. Rapid Diagnostic Test Kits: Production and sale of rapid diagnostic test kits for HIV, Malaria, Hepatitis, COVID-19, and other diseases. Capacity of 20 million tests per month.
3. Export Revenue: Export sales to international markets including India, Pakistan, European nations, and 28-35 countries globally through bilateral government contracts and UNICEF/WHO procurement.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Revital Healthcare manufactures and sells medical devices and disposables for hospitals, clinics, immunization programs, and laboratories. The core portfolio includes auto-disable syringes (including the only WHO PQS-prequalified early-activation AD syringe made in Africa), conventional and reuse-prevention syringes, rapid diagnostic test kits (HIV, Malaria, COVID-19, Hepatitis B/C, Dengue, Pregnancy, Syphilis), catheters, needles, blood collection tubes, neonatal care products such as the VAYU bCPAP system, personal protective equipment, infusion and transfusion equipment, and tubing products. Products are supplied to governments, international organizations (UNICEF, WHO), NGOs, and private healthcare providers across Africa and 28-35 countries globally.

Product overview

Revital Healthcare is Africa's largest medical device manufacturer, producing over 48+ medical devices across multiple categories. The company operates as a comprehensive medical device manufacturer with a diverse product portfolio including: syringes (conventional, insulin, reuse prevention, and WHO-prequalified auto-disable syringes), rapid diagnostic test kits (HIV, malaria, COVID-19, hepatitis, pregnancy), catheters, needles, blood collection tubes, neonatal care products (umbilical cord clamps, bCPAP systems), personal protective equipment (gowns, masks, coveralls), tubing products (infusion sets, feeding tubes, endotracheal tubes), and transfusion equipment. The company exports to over 28-35 countries globally and manufactures approximately 2.1 billion medical devices annually, making it the continent's leading medical device manufacturer.

Differentiator

Problem solved

Functional benefit

Products and services

• Auto-Disable (AD) Syringes WHO PQS-prequalified early-activation auto-disable syringes (0.5ml and other volumes) that disable at the start of injection to prevent reuse and reduce blood-borne infections. Supplied for routine immunization, COVID-19 vaccination, and pediatric immunization programs to governments, UNICEF, WHO, and NGOs across Africa and globally.
• Conventional and Reuse-Prevention Syringes Conventional syringes (ABC and DCK), fixed-dose immunization syringes (Revital Cady), insulin/hypodermic syringes, and reuse-prevention syringes for general medical, vaccination, and insulin delivery applications. WHO PQS prequalified for multiple reuse-prevention syringe SKUs.
• Rapid Diagnostic Test Kits (CADY) Rapid diagnostic test kits under the CADY brand for HIV-1/2, Malaria (P.f/Pan), SARS-CoV-2 antigen, Hepatitis B, Hepatitis C, Dengue, Syphilis, and pregnancy detection. Manufactured at Africa's largest rapid test kit production facility in Kilifi with capacity of 240 million tests per year. Supplied to governments, NGOs, and global health programs.
• Catheters Female catheters, Foley balloon catheters, suction catheters, and Nelaton catheters for urinary drainage, suction procedures, and general clinical use in hospitals and clinics.
• Needles Hypodermic needles, spinal needles, and safety needles for general injections, spinal procedures, and needle-stick injury prevention in clinical settings.
• Blood Collection Tubes Blood collection tubes for clinical specimen collection and storage in hospitals and diagnostic laboratories.
• VAYU bCPAP System and Neonatal Care Devices Non-electric VAYU bubble Continuous Positive Airway Pressure (bCPAP) system for newborn respiratory support in resource-limited settings, the VAYU Oxygen Blender System, VAYU Reusable Filter Housing, and Revital Umbilical Cord Clamp for neonatal intensive care. Deployed in partnership with the Kenyan Ministry of Health across neonatal clinics.
• Personal Protective Equipment (PPE) Revital Isolation Gown, Surgical Gown, Coverall, Bouffant Clip Cap, and Surgical Face Mask for medical isolation, surgical, and infection-prevention use by healthcare workers.
• Blood Transfusion Sets Blood transfusion/administrative sets for blood transfusion procedures in hospitals and clinical settings.
• Tubing and Infusion Products Revital Rectal Tubes (24mm-36mm), Infant Feeding Tubes (2.5mm-10mm), Endotracheal Tubes (6mm-10mm), Ryles Tubes (6mm-22mm), REFLON Intravenous Cannula with kink-resistant catheter and safety features, 3-Way Stop Cock flow control device, Burette Infusion Set (Soluset), and Infusion Sets (Economy, Regular, Premium variants) for airway management, enteral nutrition, IV fluid administration, and clinical drainage procedures.
• CADY Viral Transport Medium (VTM) Viral transport medium kits for specimen collection and transport, originally introduced during the COVID-19 pandemic as the first locally produced VTM kits in Kenya.

Quantifiable outcome

• Reduces delivery times by 80-90% compared to imported syringes
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Corning IncorporatedcoreStrategic or Co-development Partner · 7 August 2025Signed Letter of Intention to establish joint life sciences manufacturing footprint in Africa. Collaboration leverages Revital's East African facilities and regulatory infrastructure with Corning Life Sciences' expertise to scale production of essential laboratory consumables.
• Mitsui O.S.K. Lines (MOL) and MOL Logistics (MLG)coreStrategic or Co-development Partner · 28 June 2024Strategic partnership to develop state-of-the-art logistics center for medical supplies and pharmaceuticals in Mombasa Special Economic Zone. Expected investment of over KES 3 billion to create largest logistics hub in East and Central Africa.
• Kenyan Ministry of HealthcoreStrategic or Co-development Partner · 23 May 2024Partnership to equip all neonatal clinics in Kenya with Revital-made continuous positive airway pressure (CPAP) machines for babies requiring respiratory support.
• JICA (Japan International Cooperation Agency) and AUDA-NEPADcoreStrategic or Co-development Partner · 1 January 2021Home Grown Solutions Accelerator partnership selected Revital among 56 applicants. Program provided business advisory services and helped raise 700 million yen from private investors, enabling 3.5-fold increase in syringe production.
• KEMRI (Kenya Medical Research Institute)coreStrategic or Co-development PartnerPartnership for local innovation allowing home-grown research and innovation to reach delivery. Collaborates on developing medical devices tailored for African healthcare needs.
• Save the Children FoundationminorOthersInternational NGO supporting healthcare programs that receives supplies from Revital for child health initiatives across Africa.
• BCG (Boston Consulting Group)minorImplementation/ SI/ Consulting PartnerProvided business advisory services through JICA Home Grown Solutions Accelerator program to help refine growth strategy and investor presentation.
• UNICEFcoreChannel Partner/ Reseller/ DistributorGlobal procurement partner for vaccine syringes. UNICEF Global has booked all 0.5ml AD syringes Revital will manufacture in upcoming year. Contract for 50 million COVID-19 syringes to India.

Scale indicators19 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hindustan Syringes & Medical Devices: India's largest syringe and medical device manufacturer producing auto-disable and disposable syringes globally. Most direct comparator to Revital on product line (AD syringes), scale, and export orientation; key global competitor Revital displaces in African tenders.
• Terumo Corporation: Japanese medical device manufacturer with leading positions in syringes (including AD syringes for immunization), blood collection, and IV catheters. Closely comparable product mix and one of only a handful of WHO-PQS prequalified AD syringe makers globally.
• Nipro Corporation: Japanese medical device manufacturer producing syringes, needles, IV cannulas, dialysis, and glass tubing. Comparable product portfolio to Revital's syringe, catheter, and tubing categories with global manufacturing footprint.
• Retractable Technologies: US-based medical device company specializing in safety syringes and auto-disable retraction technology. Comparable niche focus on injection-safety devices with WHO-relevant product overlap.
• Shandong Weigao Group Medical Polymer: China's largest medical device consumables manufacturer producing syringes, IV catheters, needles, blood collection, and PPE. Direct comparator on product breadth, scale, and emerging-market export strategy.

Broad incumbents

• Becton, Dickinson and Company (BD): Global medical device giant producing syringes, needles, catheters, IV cannulas, and diagnostic systems. Broad incumbent across Revital's portfolio categories; sets the regulatory and scale benchmark Revital benchmarks against.
• ICU Medical (formerly Smiths Medical): Global medical device company focused on IV therapy, safety syringes, and critical care devices. Direct overlap on IV cannulas, safety syringes, and infusion sets — categories where Revital competes through REFLON and infusion products.

Regional players

• Aspen Pharmacare: Africa's largest pharmaceutical manufacturer (South Africa), supplying governments and global health agencies across the continent. Regional peer competing for the same African institutional healthcare procurement spend, though focused on pharmaceuticals rather than devices.

Emerging players

• Owen Mumford: UK-based medical device manufacturer specializing in safety syringes, auto-injectors, and blood lancets. Comparable niche focus on injection-safety devices for global health and immunization markets.
• Star Syringe: UK-based manufacturer of auto-disable (K1 Auto-Disable) syringes for UNICEF and WHO immunization programs. Direct niche peer in the AD syringe category where Revital has WHO PQS prequalification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/Revital_kenya
• Facebookfacebook.com/RevitalEPZ
• LinkedInlinkedin.com/company/revitalhealthcare
• Instagraminstagram.com/revitalkenya

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revital Healthcare